Shouxiangu(603896)
Search documents
浙江寿仙谷医药股份有限公司2025年第二次临时股东会决议公告
Shang Hai Zheng Quan Bao· 2025-12-23 18:27
Meeting Overview - The second extraordinary general meeting of shareholders was held on December 23, 2025, at the company's location in Zhejiang Province [2] - The meeting was convened by the board of directors, with the chairman, Mr. Li Mingyan, presiding over the meeting [2][3] - The meeting was witnessed by lawyers from Zhejiang Tiance Law Firm, ensuring compliance with legal and regulatory requirements [7] Attendance and Voting - A total of 9 directors were present, with 7 attending the meeting; two directors were absent due to official duties [3] - The voting process adhered to the Company Law and the company's articles of association, with all resolutions passed in accordance with the required majority [2][4] Resolutions Passed - The following proposals were approved during the meeting: 1. The 2026 annual routine related party transaction plan [4] 2. The application for a comprehensive credit limit and related guarantee matters for 2026 [4] 3. The use of temporarily idle raised funds and self-owned funds for cash management in 2026 [5] 4. The revision of the remuneration management system for directors and senior management [5] - Proposal 2 was classified as a special resolution, requiring approval from more than two-thirds of the voting rights held by shareholders present [5][6] Legal Opinion - The legal opinion provided by the witnessing lawyers confirmed that the meeting's procedures, participant qualifications, and voting processes complied with relevant laws and regulations [7]
寿仙谷:2025年第二次临时股东会决议公告
Zheng Quan Ri Bao Zhi Sheng· 2025-12-23 11:13
Core Viewpoint - Shouxiangu announced the approval of multiple proposals at its 2025 second extraordinary general meeting, including the 2026 annual related party transaction plan and the application for the 2026 comprehensive credit limit and related guarantee matters [1] Group 1 - The company held its 2025 second extraordinary general meeting on December 23 [1] - The meeting approved the proposal for the 2026 annual related party transaction plan [1] - The company also approved the proposal regarding the application for the 2026 comprehensive credit limit and related guarantee matters [1]
寿仙谷(603896) - 寿仙谷2025年第二次投资者接待日活动召开情况
2025-12-23 09:45
浙江寿仙谷医药股份有限公司 2025 年第二次投资者接待日活动召开情况 为进一步提高企业治理水平,增进公司与广大投资者之间的信息沟通,公司 2025 年第二次投资者接待日活动于 2025 年 12 月 23 日举行,公司组织投资者们 参观了寿仙谷有机国药基地、洋垄厂区(未来工厂+生物育种创新中心)及寿仙 谷文化馆,管理层就公司经营情况、科研进展等与广大投资者进行了充分交流, 同时解答了投资者较为关注的问题。具体情况如下: 一、活动基本情况 1、活动时间:2025 年 12 月 23 日 2、活动地点: (1)上午:公司基地—寿仙谷有机国药养生园;洋垄厂区—未来工厂+生物 育种创新中心 二、活动主要交流情况 1、核心产品省外营销拓展情况,以及公司对行业的发展情况的判断 答:公司在省外的业务拓展主要围绕去壁灵芝孢子粉核心产品的推广与销售。今年通过 省外渠道经销商和品牌加盟商两种模式进行渠道拓展。 从当前的宏观形势看,医药内需板块在未来一两年内整体情况将继续保持一定的复苏压 力。随着国家进入高质量发展,人民群众日益追求高水平健康的趋势不会变,中国进入银发 经济时代,中医药的功效被越来越多的人接受和认可的现实不会变, ...
寿仙谷(603896) - 寿仙谷2025年第二次临时股东会会议决议公告
2025-12-23 09:45
| | | 债券代码:113660 债券简称:寿 22 转债 浙江寿仙谷医药股份有限公司 2025年第二次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 二、 议案审议情况 审议结果:通过 表决情况: | 股东类型 | 同意 | | 反对 | | 弃权 | | | --- | --- | --- | --- | --- | --- | --- | | | 票数 | 比例(%) | 票数 | 比例 (%) | 票数 | 比例 (%) | | A 股 | 3,798,315 | 92.8616 | 226,721 | 5.5429 | 65,260 | 1.5955 | 2、 议案名称:关于公司申请 2026 年度综合授信额度及相关担保事项的议案 本次会议是否有否决议案:无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 218 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数(股) | 75,843,185 | | 3、出席会议的股东所持有表决权股 ...
寿仙谷(603896) - 浙江天册律师事务所关于寿仙谷2025年第二次临时股东会的法律意见书
2025-12-23 09:45
下 天册律师事务所 T T & C L A W F L R M 法律意见书 浙江天册律师事务所 关于 浙江寿仙谷医药股份有限公司 2025 年第二次临时股东会的 法律意见书 天册律师事务所 T & C LAW FIRM 浙江省杭州市杭大路 1 号黄龙世纪广场 A 座 11 楼 310007 电话: 0571-87901111 传真: 0571-87901500 2025 2025 1 12 23 2025 12 23 9:15-9:25 9:30-11:30 13:00-15:00 2025 12 23 9:15-15:00 2025 2025 11 29 1. 2026 2. 2026 3. 2026 4. < > 1 2 3 4 2 16 73,471,077 37.0610 % 202 2,372,108 1.1966% 1. 2026 3,798,315 226,721 65,260 92.8616% 2. 2026 75,518,704 271,021 53,460 99.5721% 3. 2026 75,435,464 349,981 57,740 99.4624% 3 4. < > 75,502 ...
寿仙谷:公司已进驻阿里国际站和亚马逊平台
Zheng Quan Ri Bao Wang· 2025-12-15 13:43
Group 1 - The company, Shouxiangu (603896), has entered Alibaba International Station and Amazon platforms but has not yet achieved direct product exports to EU countries [1] - The company will fulfill its information disclosure obligations in a timely manner if there are significant developments in its international business [1]
寿仙谷:目前公司互联网销售平台主要为天猫、京东等
Zheng Quan Ri Bao Wang· 2025-12-15 13:43
Group 1 - The company, Shouxiangu (603896), has stated that its main online sales platforms include Tmall, JD.com, its official website, Shouxiangu official mall (WeChat), Douyin, and Kuaishou [1] - The company has not disclosed the sales proportion from each major platform [1]
寿仙谷:目前公司尚未实现产品直接出口欧盟国家
Ge Long Hui· 2025-12-15 10:49
Group 1 - The company, Shouxiangu (603896.SH), has entered the Alibaba International Station and Amazon platforms [1] - Currently, the company has not achieved direct product exports to EU countries [1]
寿仙谷(603896.SH):目前公司尚未实现产品直接出口欧盟国家
Ge Long Hui· 2025-12-15 10:47
格隆汇12月15日丨寿仙谷(603896.SH)在投资者互动平台表示,目前,公司已进驻阿里国际站和亚马逊 平台,尚未实现产品直接出口欧盟国家。 ...
寿仙谷:已进驻阿里国际站和亚马逊平台,尚未实现产品直接出口欧盟国家
Jin Rong Jie· 2025-12-15 10:31
声明:市场有风险,投资需谨慎。本文为AI基于第三方数据生成,仅供参考,不构成个人投资建议。 本文源自:市场资讯 有投资者在互动平台向寿仙谷提问:"请问近两年是否出口欧盟国家?" 针对上述提问,寿仙谷回应称:"您好!感谢您的关注!目前,公司已进驻阿里国际站和亚马逊平台, 尚未实现产品直接出口欧盟国家。公司如有国际业务重大进展,将严格按规定及时履行信息披露义务, 敬请关注公司公告。谢谢!" 作者:公告君 ...